Clover Health Investments, Corp.
NASDAQ:CLOVMedical - Healthcare Plans
+$0.17 today
- Market cap
- $1.98B
- Beta
- 2.48
- P/E (TTM)
- -45.6
- EPS (TTM)
- -$0.11
Volume 7.24M
Average 7.31M
Income Statement
Follow revenue through to earnings.
Revenue
$1.92B
FY 2025 · Annual
+40.3% YoYOperating Income
-$85.53M
FY 2025 · Annual
Net Income
-$85.55M
FY 2025 · Annual
Income Statement
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.47B | 1.1B | 1.26B | 1.37B | 1.92B |
| Cost of Revenue | 1.55B | 993.07M | 1B | 1.01B | 1.57B |
| Gross Profit | (79.18M) | 103.48M | 255.95M | 364.8M | 355.88M |
| Gross Margin | -5.4% | 9.4% | 20.3% | 26.6% | 18.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 445.75M | 482.4M | 440.25M | 408.93M | 176.32M |
| Operating Expenses | 557.81M | 390.14M | 461.28M | 410.55M | 441.43M |
| Depreciation & Amortization | 1.25M | 1.19M | 2.51M | 1.33M | 1.69M |
| EBITDA | (569.6M) | (252.03M) | (207.63M) | (44.94M) | (83.86M) |
| EBITDA Margin | -38.7% | -23.0% | -16.5% | -3.3% | -4.4% |
| Operating Income | (636.99M) | (286.66M) | (205.33M) | (45.75M) | (85.53M) |
| Operating Margin | -43.3% | -26.1% | -16.3% | -3.3% | -4.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 16.91M | 1.36M | 7K | 0 | 0 |
| Other Income / Expenses | 49.24M | 32.08M | (4.82M) | (517K) | (20K) |
| Income Before Tax | (587.76M) | (254.58M) | (210.15M) | (46.27M) | (85.55M) |
| Pre-Tax Margin | -39.9% | -23.2% | -16.7% | -3.4% | -4.4% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (587.76M) | (339.57M) | (213.36M) | (43.01M) | (85.55M) |
| Net Margin | -39.9% | -31.0% | -16.9% | -3.1% | -4.4% |
| EPS (Basic) | (1.25) | (0.71) | (0.45) | (0.09) | (0.17) |
| EPS (Diluted) | (1.25) | (0.71) | (0.45) | (0.09) | (0.17) |
| 470.85M | 476.24M | 482.18M | 490.02M | 517.24M | |
| 470.85M | 476.24M | 482.18M | 490.02M | 517.24M |
CLOV Earnings Waterfall · TTM
NASDAQ:CLOV · Revenue to Net Income
Key Ratios
Analysis
$2.5B of revenue converted into -$18.4M of net income for the selected period. Gross margin is 18.0% and net margin is -1.9%, showing how much revenue survives after costs and taxes. EPS is $-0.04, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| 10-Q | Quarterly report | Nov 6, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 20, 2026 |
How much revenue does CLOV generate?
Clover Health Investments, Corp. (CLOV) reported $1.92B of revenue in fiscal 2025.
Is CLOV profitable?
Clover Health Investments, Corp. (CLOV) reported -$85.55M of net income, with a net margin of -4.4%.
Continue the stock analysis
Jump to another research area for this company.